Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.48 |
| ▸ | CRBN | Q96SW2 | 17/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | DDB1 | Q16531 | 16/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3800179 | 0.90 | MAP3K14 (0.44) | MAP3K14CRBNSMN1; SMN2DDB1CYP19A1 | |
| SCHEMBL22192782 | 0.86 | MAP3K14 (0.41) | MAP3K14CRBNSMN1; SMN2DDB1CYP19A1 | |
| Propionic Acid SCHEMBL2689345 | 0.82 | SMN1; SMN2 (0.40) | MAP3K14CRBNSMN1; SMN2DDB1 | |
| SCHEMBL13673930 | 0.82 | — | — | |
| SCHEMBL211974 | 0.80 | — | — | |
| SCHEMBL21305366 | 0.80 | — | — | |
| SCHEMBL1024468 | 0.80 | — | — | |
| SCHEMBL807677 | 0.80 | — | — | |
| SCHEMBL4774020 | 0.80 | — | — | |
| SCHEMBL22702164 | 0.75 | MAP3K14 (0.40) | MAP3K14CRBNSMN1; SMN2DDB1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023157822-A1 | RADIOACTIVE COMPLEX OF ANTI-VEGF ANTIBODY, AND RADIOPHARMACEUTICAL | 日本メジフィジックス株式会社 | 2023-08-24 | — | — | WO | disclosed |
| WO-2023033022-A1 | RADIOACTIVE COMPLEX OF DEGLYCOSYLATED ANTIBODY AND RADIOACTIVE PHARMACEUTICAL PRODUCT | 日本メジフィジックス株式会社 | 2023-03-09 | — | — | WO | disclosed |
| WO-2023277144-A1 | HUMANIZED ANTIBODY CAPABLE OF BINDING TO HEG1 PROTEIN, AND COMPLEX OF SAID ANTIBODY AND RADIOACTIVE NUCLEAR SPECIES | 日本メジフィジックス株式会社 | 2023-01-05 | — | — | WO | disclosed |
| WO-2022224980-A1 | RADIOACTIVE COMPLEX OF ANTI-CD20 ANTIBODY, AND RADIOPHARMACEUTICAL | 日本メジフィジックス株式会社 | 2022-10-27 | — | — | WO | disclosed |
| WO-2022211051-A1 | RADIOACTIVE COMPLEX OF ANTI-EGFR ANTIBODY, AND RADIOPHARMACEUTICAL | 日本メジフィジックス株式会社 | 2022-10-06 | — | — | WO | disclosed |
| US-20030180957-A1 | Target and method | SENSE PROTEOMIC LIMITED | 2003-09-25 | — | — | US | disclosed |
| WO-2003056344-A2 | PROTEIN ANALYSIS USING MASS SPECTROMETRY | SENSE PROTEOMIC LIMITED (GB) | 2003-07-10 | — | — | WO | disclosed |